A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.
Prif Awdur: | Islam, Nahidul |
---|---|
Awduron Eraill: | Talukder, Mesbah |
Fformat: | Traethawd Ymchwil |
Iaith: | English |
Cyhoeddwyd: |
Brac University
2023
|
Pynciau: | |
Mynediad Ar-lein: | http://hdl.handle.net/10361/22025 |
Eitemau Tebyg
-
TNF-α inhibitor-induced alopecia in psoriatic disease patients: a pharmacovigilance study
gan: Afroza, Halima
Cyhoeddwyd: (2024) -
Biologics and Biosimilars as Treatment Options for Psoriasis
gan: Moya, Amena Khatun
Cyhoeddwyd: (2023) -
Association of GLP-1 receptor agonists and risk of pancreatitis: a pharmacovigilance study based on FAERS database
gan: Bishakha, Adwiza Chakraborty
Cyhoeddwyd: (2024) -
Safety and efficacy of dutasteride for male Androgenetic Alopecia
gan: Islam, S.M. Zahidul
Cyhoeddwyd: (2024) -
Relationship between SGLT2 inhibitor use and risk of lower limb amputations: a pharmacovigilance study
gan: Khandker, Tahia Anjum
Cyhoeddwyd: (2024)